SOUNDVIEW TECHNOLOGY GROUP INC·4

Jan 20, 2:30 PM ET

ROBBINS STUART M 4

4 · SOUNDVIEW TECHNOLOGY GROUP INC · Filed Jan 20, 2004

Insider Transaction Report

Form 4
Period: 2004-01-16
Transactions
  • Disposition to Issuer

    Stock Option

    2004-01-1624,0000 total
    Exercise: $9.70Exp: 2012-06-07Common Stock, par value $.01 per share (24,000 underlying)
  • Disposition to Issuer

    Stock Option

    2004-01-1610,0000 total
    Exercise: $10.16Exp: 2013-07-23Common Stock, par value $.01 per share (10,000 underlying)
Footnotes (2)
  • [F1]This option, which provided for 4,000 options to vest each quarter in 2002 beginning on June 30, 2002 and 1,000 per quarter thereafter, was cancelled pursuant to the Agreement and Plan of Merger, dated November 18, 2003, among The Charles Schwab Corporation, Shakespeare Merger Corporation and SoundView Technology Group, Inc. in exchange for a cash payment of $139,200, representing the difference between the exercise price of the option and the market value of the underlying common stock on the effective date of the merger ($15.50). The cash payment attributable to the unvested portion of the option will be held in an account for the benefit of Mr. Robbins and will be payable to Mr. Robbins upon the same schedule and in amounts corresponding to the vesting of the underlying cancelled option.
  • [F2]This option, which provided for vesting in sixteen equal quarterly installments beginning on September 30, 2003, was cancelled in the merger in exchange for a cash payment of $53,400, representing the difference between the exercise price of the option and the market value of the underlying common stock on the effective date of the merger ($15.50). The cash payment attributable to the unvested portion of the option will be held in an account for the benefit of Mr. Robbins and will be payable to Mr. Robbins upon the same schedule and in amounts corresponding to the vesting of the underlying cancelled option.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT